vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.
SMARTFINANCIAL INC. is the larger business by last-quarter revenue ($53.8M vs $39.6M, roughly 1.4× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 25.4%, a 10.5% gap on every dollar of revenue. Over the past eight quarters, SMARTFINANCIAL INC.'s revenue compounded faster (15.4% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
SBC vs SMBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $53.8M |
| Net Profit | $14.2M | $13.7M |
| Gross Margin | 73.1% | — |
| Operating Margin | 32.5% | — |
| Net Margin | 35.9% | 25.4% |
| Revenue YoY | -10.9% | — |
| Net Profit YoY | 117.2% | 21.6% |
| EPS (diluted) | $0.15 | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $53.8M | ||
| Q4 25 | $39.6M | $53.3M | ||
| Q3 25 | $43.4M | $51.1M | ||
| Q2 25 | $43.4M | $49.2M | ||
| Q1 25 | $47.3M | $46.8M | ||
| Q4 24 | $44.4M | $46.8M | ||
| Q3 24 | $53.1M | $44.2M | ||
| Q2 24 | $53.1M | $40.4M |
| Q1 26 | — | $13.7M | ||
| Q4 25 | $14.2M | $13.7M | ||
| Q3 25 | $12.8M | $13.7M | ||
| Q2 25 | $2.5M | $11.7M | ||
| Q1 25 | $21.5M | $11.3M | ||
| Q4 24 | $6.5M | $9.6M | ||
| Q3 24 | $2.8M | $9.1M | ||
| Q2 24 | $18.5M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 73.1% | — | ||
| Q3 25 | 70.6% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 79.7% | — | ||
| Q4 24 | 76.3% | — | ||
| Q3 24 | 81.5% | — | ||
| Q2 24 | 74.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 32.5% | 31.3% | ||
| Q3 25 | 36.6% | 33.2% | ||
| Q2 25 | 33.6% | 29.0% | ||
| Q1 25 | 51.1% | 29.0% | ||
| Q4 24 | 10.6% | 26.5% | ||
| Q3 24 | 26.1% | 24.3% | ||
| Q2 24 | 51.4% | 25.6% |
| Q1 26 | — | 25.4% | ||
| Q4 25 | 35.9% | 25.7% | ||
| Q3 25 | 29.6% | 26.8% | ||
| Q2 25 | 5.7% | 23.8% | ||
| Q1 25 | 45.4% | 24.0% | ||
| Q4 24 | 14.7% | 20.6% | ||
| Q3 24 | 5.3% | 20.7% | ||
| Q2 24 | 34.8% | 19.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | $0.15 | $0.81 | ||
| Q3 25 | $0.12 | $0.81 | ||
| Q2 25 | $0.02 | $0.69 | ||
| Q1 25 | $0.21 | $0.67 | ||
| Q4 24 | $0.05 | $0.57 | ||
| Q3 24 | $0.03 | $0.54 | ||
| Q2 24 | $0.20 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | $346.1M |
| Total DebtLower is stronger | $42.8M | — |
| Stockholders' EquityBook value | $248.3M | $562.2M |
| Total Assets | $380.4M | $5.9B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $346.1M | ||
| Q4 25 | $164.1M | $464.4M | ||
| Q3 25 | $127.4M | $557.1M | ||
| Q2 25 | $152.7M | $365.1M | ||
| Q1 25 | $132.1M | $423.0M | ||
| Q4 24 | $125.0M | $387.6M | ||
| Q3 24 | $137.4M | $192.9M | ||
| Q2 24 | — | $342.8M |
| Q1 26 | — | — | ||
| Q4 25 | $42.8M | — | ||
| Q3 25 | $21.1M | $1.3M | ||
| Q2 25 | $7.1M | $7.0M | ||
| Q1 25 | $6.9M | $7.6M | ||
| Q4 24 | $6.6M | $8.1M | ||
| Q3 24 | $823.2K | $9.0M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | $562.2M | ||
| Q4 25 | $248.3M | $552.4M | ||
| Q3 25 | $248.0M | $538.4M | ||
| Q2 25 | $244.6M | $519.0M | ||
| Q1 25 | $226.4M | $505.8M | ||
| Q4 24 | $195.1M | $491.3M | ||
| Q3 24 | $205.0M | $489.0M | ||
| Q2 24 | $8.8M | $472.5M |
| Q1 26 | — | $5.9B | ||
| Q4 25 | $380.4M | $5.9B | ||
| Q3 25 | $321.4M | $5.8B | ||
| Q2 25 | $315.3M | $5.5B | ||
| Q1 25 | $284.6M | $5.4B | ||
| Q4 24 | $266.1M | $5.3B | ||
| Q3 24 | $296.5M | $4.9B | ||
| Q2 24 | $19.5M | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | 0.00× | ||
| Q2 25 | 0.03× | 0.01× | ||
| Q1 25 | 0.03× | 0.02× | ||
| Q4 24 | 0.03× | 0.02× | ||
| Q3 24 | 0.00× | 0.02× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | — |
| Free Cash FlowOCF − Capex | $51.2M | — |
| FCF MarginFCF / Revenue | 129.3% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 3.66× | — |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $52.0M | $61.7M | ||
| Q3 25 | $-20.9M | $16.9M | ||
| Q2 25 | $-8.3M | $14.0M | ||
| Q1 25 | $1.9M | $14.3M | ||
| Q4 24 | $-7.3M | $52.7M | ||
| Q3 24 | $5.0M | $12.4M | ||
| Q2 24 | $19.2M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $51.2M | $59.3M | ||
| Q3 25 | $-20.9M | $16.6M | ||
| Q2 25 | $-8.6M | $13.2M | ||
| Q1 25 | $1.7M | $13.4M | ||
| Q4 24 | $-7.9M | $46.3M | ||
| Q3 24 | $4.6M | $11.3M | ||
| Q2 24 | $18.3M | $15.4M |
| Q1 26 | — | — | ||
| Q4 25 | 129.3% | 111.3% | ||
| Q3 25 | -48.3% | 32.4% | ||
| Q2 25 | -19.9% | 26.9% | ||
| Q1 25 | 3.5% | 28.5% | ||
| Q4 24 | -17.8% | 98.9% | ||
| Q3 24 | 8.7% | 25.7% | ||
| Q2 24 | 34.5% | 38.2% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 4.5% | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | 0.7% | 1.6% | ||
| Q1 25 | 0.5% | 2.0% | ||
| Q4 24 | 1.3% | 13.7% | ||
| Q3 24 | 0.8% | 2.4% | ||
| Q2 24 | 1.6% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.66× | 4.50× | ||
| Q3 25 | -1.63× | 1.23× | ||
| Q2 25 | -3.39× | 1.20× | ||
| Q1 25 | 0.09× | 1.27× | ||
| Q4 24 | -1.12× | 5.47× | ||
| Q3 24 | 1.77× | 1.36× | ||
| Q2 24 | 1.04× | 2.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
